US Food and Drug Administration's Directive to Deal With Delayed Confirmatory Trials: Lessons From Pralatrexate and Belinostat for T-Cell Lymphoma
Journal of Clinical Oncology · 2024
DOI: 10.1200/jco.24.00100 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Oncology, 2024. Verfasst von Edward R Scheffer Cliff und 3 weiteren Autor:innen. Beteiligte Einrichtung: Program On Regulation, Therapeutics, And Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hos…. Hauptthemen laut MEDLINE: United States Food and Drug Administration, Aminopterin, Lymphoma, T-Cell, Sulfonamides. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben.
Abstract (Originalsprache)
The FDA's directive to deal with delayed confirmatory trials: lessons from pralatrexate and belinostat for T-cell lymphoma
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Program On Regulation, Therapeutics, And Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, MA.
- Harvard Medical School, Boston, MA.
- Division of Oncology, Department of Medicine, Washington University School of Medicine, St Louis, MO.
- Siteman Cancer Center, St Louis, MO.
ORCID-Profile: Edward R Scheffer Cliff, David A Russler-Germain, Aaron S Kesselheim
Zitieren
APA
Cliff, E. R. S., Russler-Germain, D. A., Daval, C. J. R., & Kesselheim, A. S. (2024). US Food and Drug Administration's Directive to Deal With Delayed Confirmatory Trials: Lessons From Pralatrexate and Belinostat for T-Cell Lymphoma. Journal of Clinical Oncology. https://doi.org/10.1200/jco.24.00100
Vancouver
Cliff ERS, Russler-Germain DA, Daval CJR, Kesselheim AS. US Food and Drug Administration's Directive to Deal With Delayed Confirmatory Trials: Lessons From Pralatrexate and Belinostat for T-Cell Lymphoma. Journal of Clinical Oncology. 2024. doi:10.1200/jco.24.00100
BibTeX
@article{Cliff2024,
author = {Cliff, Edward R Scheffer and Russler-Germain, David A and Daval, C Joseph Ross and Kesselheim, Aaron S},
title = {US Food and Drug Administration's Directive to Deal With Delayed Confirmatory Trials: Lessons From Pralatrexate and Belinostat for T-Cell Lymphoma},
journal = {Journal of Clinical Oncology},
year = {2024},
doi = {10.1200/jco.24.00100}
}
EUVIMED